This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to viral gastroenteritis (rotaviruses, noroviruses, caliciviruses, adenoviruses, sapoviruses, astroviruses). It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to Prion disease (CJD, vCJD). It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to rotaviruses. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to human coronaviruses (SARS-CoV, MERS-CoV and SARS-CoV-2. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to Toxoplasma gondii. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to HIV. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter provides guidance on how to send specimens to a virology laboratory, including the need to provide full and accurate patient information, relevant clinical information, how to package and transport specimens and the need to send the correct specimens.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to rabies virus. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to HSV. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the non-molecular techniques (virus culture, electron microscopy, detection of viral antigens and point-of-care tests) used to detect viruses in patient secretions or tissue which can provide direct evidence of current or ongoing infection.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to human CMV. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter provides details of the viruses and other organisms that are more severe in immunocompromised patients (HIV, CMV, EBV, HSV, VZV, HHV6, HHV7, HHV8, adenoviruses, influenzaviruses, parainfluenzaviruses, RSV, SARS-CoV-2, HBV, HEV, polyomaviruses, papillomaviruses, parvovirus, T gondii). It gives details of symptoms, diagnosis, treatment and strategies for reducing the risk of severe symptoms.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to influenza viruses. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter provides details of the viruses associated with malignancies (HBV, HCV, HTLV1, EBV, HPVs, HHV8). It gives details of symptoms, risk factors, treatment and prevention strategies.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to parainfluenzaviruses. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to HAV. It provides information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.